Barclays raised the firm’s price target on DaVita (DVA) to $158 from $143 and keeps an Equal Weight rating on the shares post the Q4 report. The company’s 2026 earnings outlook handily beat Street estimates driven by continued share repurchase, the elimination of Mozarc losses, and lower debt from refinancing, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DVA:
